Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Multinational Study of MCLA-117 in Acute Myelogenous Leukemia

NCT03038230 is registered in ClinicalTrials.gov with Merus B.V. as lead sponsor.

NCT NCT03038230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03038230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Multinational Study of MCLA-117 in Acute Myelogenous Leukemia
Lead sponsor
Merus B.V.
Phase
Phase 1
Overall status
Terminated
Start date
April 30, 2016
Completion date
May 11, 2021
Enrollment
80 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acute myelogenous leukemia, acute myeloid leukemia